Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2654

Actual shortage: 249 (9%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2396 (90%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

329 (11%)

Overdue reports

26 (10%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Actual shortage 2023-04-27 2024-04-25 190785
TEVA-MORPHINE SR 15MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-08 2023-06-27 194125
TEVA-QUETIAPINE XR 150MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-08 2023-07-12 194163
TEVA-DILTIAZEM XC 360MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-08 2024-01-08 194191
TEVA-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-16 2023-10-06 195078
TEVA-QUETIAPINE XR 150MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-16 2023-07-05 195118
TEVA-MORPHINE SR 15MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-16 2023-06-21 195210
TEVA-DILTIAZEM XC 360MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-20 2023-07-05 195763
TEVA-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-20 2023-07-05 195827
TEVA-MORPHINE SR 30MG TABLET (EXTENDED-RELEASE) Resolved 2023-07-04 2023-08-04 197169
TEVA-DILTIAZEM XC 240MG TABLET (EXTENDED-RELEASE) Resolved 2023-07-19 2023-12-14 199199
TEVA-QUETIAPINE XR 50MG TABLET (EXTENDED-RELEASE) Resolved 2023-07-21 2023-08-18 199554
TEVA-DILTIAZEM XC 300MG TABLET (EXTENDED-RELEASE) Resolved 2023-07-21 2024-01-11 199717
TEVA-DILTIAZEM XC 180MG TABLET (EXTENDED-RELEASE) Resolved 2023-10-12 2023-12-07 206904
TEVA-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Actual shortage 2023-11-03 2024-04-11 209148
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2023-11-09 2023-12-07 209672
ACT CLARITHROMYCIN XL 500MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-01-11 2024-04-11 215737
TEVA-DILTIAZEM XC 240MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-01-11 2024-04-25 215740
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2024-01-11 2024-02-22 215743
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2024-01-11 2024-02-22 215746

Showing 2601 to 2620 of 2654

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ACT NABILONE 1MG CAPSULE Discontinued 2019-10-31 2019-11-01 97581
NOVAMOXIN 250MG CAPSULE Discontinued 2020-01-24 2020-01-24 104289
TEVA-QUININE 300MG CAPSULE Discontinued 2020-01-24 2020-01-24 104294
TEVA-TRANDOLAPRIL 0.5MG CAPSULE Discontinued 2020-07-10 2020-07-10 120021
TEVA-TRANDOLAPRIL 1MG CAPSULE Discontinued 2020-07-10 2020-07-10 120024
TEVA-TRANDOLAPRIL 2MG CAPSULE Discontinued 2020-07-10 2020-07-10 120027
TEVA-TRANDOLAPRIL 4MG CAPSULE Discontinued 2020-07-10 2020-07-10 120030
TEVA-PREGABALIN 75MG CAPSULE Discontinued 2020-07-10 2020-07-10 120033
ACT CELECOXIB 100MG CAPSULE To be discontinued 2020-09-03 2020-09-03 123648
ACT CELECOXIB 200MG CAPSULE To be discontinued 2020-09-03 2020-09-03 123651
TEVA-QUININE 200MG CAPSULE Discontinued 2020-10-08 2020-10-09 125976
TEVA-CEPHALEXIN 500MG CAPSULE Discontinued 2020-10-08 2020-10-09 125979
ACT NABILONE 0.5MG CAPSULE Discontinued 2020-10-15 2020-10-15 126452
ACT CELECOXIB 200MG CAPSULE Discontinued 2021-02-12 2021-02-12 133874
ACT CELECOXIB 100MG CAPSULE Discontinued 2021-02-12 2021-02-12 133880
ACT NABILONE 0.5MG CAPSULE Discontinued 2021-09-23 2021-09-23 146066
TEVA-DULOXETINE 30MG CAPSULE (DELAYED RELEASE) Discontinued 2020-06-11 2020-06-11 117491
TEVA-DULOXETINE 60MG CAPSULE (DELAYED RELEASE) Discontinued 2020-06-11 2020-06-11 117494
ACT VENLAFAXINE XR 75.0MG CAPSULE (EXTENDED RELEASE) Discontinued 2018-10-22 2018-10-22 65292
ACT VENLAFAXINE XR 75.0MG CAPSULE (EXTENDED RELEASE) Discontinued 2018-10-22 2018-10-22 65295

Showing 41 to 60 of 250